Literature DB >> 16201110

Relationships between hemodynamic alterations and Child-Pugh Score in patients with cirrhosis.

Dinc Dincer1, Fatih Besisk, Onur Demirkol, Kadir Demir, Sabahattin Kaymakoglu, Yilmaz Cakaloglu, Atilla Okten.   

Abstract

BACKGROUND/AIMS: In this study, central and nonsplanchnic hemodynamic alterations in liver cirrhosis and correlation between Child-Pugh Score and these hemodynamic alterations were evaluated.
METHODOLOGY: With this aim, angiotensin-I, aldosterone, femoral blood flow, cardiac index, free water clearance and renal blood flow index were evaluated in 30 cirrhotic patients and 10 healthy control subjects.
RESULTS: Child-Pugh score was found to be directly related with serum levels of angiotensin-I and aldosterone, cardiac and renal blood flow index (r = 0.60 - p < 0.001, r = 0.57 - p < 0.01, r = 0.55 - p < 0.01 and r = 0.65 - p < 0.001 respectively), and indirectly related with free water clearance and femoral blood flow (r = 0 .72 -p < 0 .001, r = 0.71 -p < 0 .001 respectively).
CONCLUSIONS: We concluded that, in patients with cirrhosis, as the Child-Pugh score becomes greater angiotensin-I and aldosterone, cardiac output and non-splanchnic vasoconstriction progressively increase, on the other hand free water clearance and renal perfusion progressively decrease. Alterations in cardiac index and femoral artery blood flow begin before ascites formation. And the hyperdynamic circulation is a primary event independent of the central blood volume.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16201110

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance.

Authors:  Trevor N Johnson; Koen Boussery; Karen Rowland-Yeo; Geoffrey T Tucker; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2010-03       Impact factor: 6.447

2.  Accuracy of arterial pressure waveform analysis for cardiac output measurement in comparison with thermodilution methods in patients undergoing living donor liver transplantation.

Authors:  Kozaburo Akiyoshi; Tadashi Kandabashi; Junko Kaji; Ken Yamaura; Hayashi Yoshimura; Kazuo Irita; Sumio Hoka
Journal:  J Anesth       Date:  2011-01-19       Impact factor: 2.078

3.  Physiology-based simulations of a pathological condition: prediction of pharmacokinetics in patients with liver cirrhosis.

Authors:  Andrea N Edginton; Stefan Willmann
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

4.  Transporter Expression in Liver Tissue from Subjects with Alcoholic or Hepatitis C Cirrhosis Quantified by Targeted Quantitative Proteomics.

Authors:  Li Wang; Carol Collins; Edward J Kelly; Xiaoyan Chu; Adrian S Ray; Laurent Salphati; Guangqing Xiao; Caroline Lee; Yurong Lai; Mingxiang Liao; Anita Mathias; Raymond Evers; William Humphreys; Cornelis E C A Hop; Sean C Kumer; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2016-08-19       Impact factor: 3.922

5.  Clinical Aspects and Prognosis Evaluation of Cirrhotic Patients Hospitalized with Acute Kidney Injury.

Authors:  Célio Geraldo de Oliveira Gomes; Marcus Vinicius Melo de Andrade; Ludmila Resende Guedes; Henrique Carvalho Rocha; Roberto Gardone Guimarães; Fernando Antônio Castro Carvalho; Eduardo Garcia Vilela
Journal:  Can J Gastroenterol Hepatol       Date:  2019-03-03

6.  Applications of Physiologically Based Pharmacokinetic Modeling of Rivaroxaban-Renal and Hepatic Impairment and Drug-Drug Interaction Potential.

Authors:  Stefan Willmann; Katrin Coboeken; Stefanie Kapsa; Kirstin Thelen; Markus Mundhenke; Kerstin Fischer; Burkhard Hügl; Wolfgang Mück
Journal:  J Clin Pharmacol       Date:  2021-01-06       Impact factor: 3.126

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.